Can US FDA Share Drug Sponsor’s Information With Patent & Trademark Office?

Patent office could request information from FDA that is material to patentability, speakers at USPTO-FDA ‘listening session’ advise the agencies. Information exchange raises questions about trade secret protection and burdens on agencies.

FDA_USPTO_molecules_patent
Stakeholders recommend FDA share drug sponsor's information with USPTO • Source: Nielsen Hobbs; Pink Sheet | Shutterstock images

More from Generics

More from Biosimilars & Generics